Award

Valganciclovir & Caspofungin Generic Medicines

THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")

This public procurement record has 2 releases in its history.

Award

31 Mar 2017 at 00:00

Tender

24 Nov 2016 at 00:00

Summary of the contracting process

The procurement process involves the Common Services Agency, commonly referred to as NHS National Services Scotland, which is located at Gyle Square, Edinburgh. The tender titled "Valganciclovir & Caspofungin Generic Medicines" aims to supply various health-related products, specifically Valganciclovir tablets, oral solutions, and Caspofungin vials, to Health Boards across Scotland. The procurement method used is an open procedure, and the tender is currently in the award stage, having concluded on 6th March 2017. The contract duration includes an initial twelve-month period with an option for a twenty-four-month extension, thus creating valuable ongoing supply opportunities with an estimated value of £2,250,000.

This tender presents significant opportunities for businesses operating within the pharmaceutical and healthcare sectors, specifically those specialising in the manufacturing and supply of medicines. Companies that can demonstrate compliance with the relevant UK Marketing Authorisations, quality certifications such as ISO 9001, and adherence to safety guidelines are well-positioned to compete successfully. The open procurement method allows a wide range of suppliers to participate, fostering healthy competition and potential growth for those able to meet the requirements set by NHS Scotland.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Valganciclovir & Caspofungin Generic Medicines

Notice Description

The supply of a Valganciclovir tablets and oral solution and Caspofungin 50mg and 70mg Powder for Solution for Infusion vials to Health Boards across NHS Scotland.

Lot Information

Lot 1

This framework agreement is for the supply of the following medicines to NHS Scotland, Valganciclovir 50mg/ml powder for oral solution, Valganciclovir 450mg tablets, Caspofungin 50mg and 70 mg powder for solution for infusion. Each product line was treated as an individual lot and has been awarded as a single supplier framework.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement by up to a further two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension.

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000471605
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR278757
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

33631100 - Antifungals for dermatological use

33651400 - Antivirals for systemic use

Notice Value(s)

Tender Value
£2,250,000 £1M-£10M
Lots Value
£2,250,000 £1M-£10M
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
31 Mar 20178 years ago
Submission Deadline
10 Jan 2017Expired
Future Notice Date
Not specified
Award Date
6 Mar 20178 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Not Specified
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")
Contact Name
Hazel Johnstone, Nadia Crockett
Contact Email
hazel.johnstone@nhs.net, nadia.crockett@nhs.net
Contact Phone
+44 1698794410, +44 1698794460

Buyer Location

Locality
LARKHALL
Postcode
ML9 2QX
Post Town
Motherwell
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-r6ebe6-0000471605-2017-03-31T00:00:00Z",
    "date": "2017-03-31T00:00:00Z",
    "ocid": "ocds-r6ebe6-0000471605",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-19",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
            },
            "address": {
                "streetAddress": "National Procurement, 2 Swinhill Avenue",
                "locality": "Larkhall",
                "region": "UKM",
                "postalCode": "ML9 2QX"
            },
            "contactPoint": {
                "name": "Nadia Crockett",
                "email": "nadia.crockett@nhs.net",
                "telephone": "+44 1698794460",
                "url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.htmlh"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody",
                "reviewBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
            }
        },
        {
            "id": "org-29",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")"
            },
            "address": {
                "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
                "locality": "Edinburgh",
                "region": "UKM",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "name": "Hazel Johnstone",
                "email": "hazel.johnstone@nhs.net",
                "telephone": "+44 1698794410",
                "url": "http://"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody",
                "reviewBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/"
            }
        }
    ],
    "buyer": {
        "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"the Authority\")",
        "id": "org-29"
    },
    "tender": {
        "id": "NP46517",
        "title": "Valganciclovir & Caspofungin Generic Medicines",
        "description": "The supply of a Valganciclovir tablets and oral solution and Caspofungin 50mg and 70mg Powder for Solution for Infusion vials to Health Boards across NHS Scotland.",
        "status": "complete",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "33600000",
                        "scheme": "CPV"
                    },
                    {
                        "id": "33651400",
                        "scheme": "CPV"
                    },
                    {
                        "id": "33631100",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    },
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "value": {
            "amount": 2250000,
            "currency": "GBP"
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "mainProcurementCategory": "goods",
        "submissionMethod": [
            "electronicSubmission"
        ],
        "submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
        "tenderPeriod": {
            "endDate": "2017-01-10T12:00:00Z"
        },
        "awardPeriod": {
            "startDate": "2017-01-10T12:00:00Z"
        },
        "documents": [
            {
                "id": "NOV265034",
                "documentType": "contractNotice",
                "title": "Valganciclovir & Caspofungin Generic Medicines",
                "description": "The supply of a Valganciclovir tablets and oral solution and Caspofungin 50mg and 70mg Powder for Solution for Infusion vials to Health Boards across NHS Scotland.",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV265034",
                "format": "text/html"
            },
            {
                "id": "APR278757",
                "documentType": "awardNotice",
                "title": "Valganciclovir & Caspofungin Generic Medicines",
                "description": "The supply of a Valganciclovir tablets and oral solution and Caspofungin 50mg and 70mg Powder for Solution for Infusion vials to Health Boards across NHS Scotland.",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR278757",
                "format": "text/html"
            }
        ],
        "lots": [
            {
                "id": "1",
                "description": "This framework agreement is for the supply of the following medicines to NHS Scotland, Valganciclovir 50mg/ml powder for oral solution, Valganciclovir 450mg tablets, Caspofungin 50mg and 70 mg powder for solution for infusion. Each product line was treated as an individual lot and has been awarded as a single supplier framework.",
                "status": "complete",
                "value": {
                    "amount": 2250000,
                    "currency": "GBP"
                },
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 360
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "The Authority is entitled at its sole discretion to extend the Framework Agreement by up to a further two (2) periods of up to twelve (12) months each by giving a minimum of three (3) months written notice of such extension."
                }
            }
        ],
        "bidOpening": {
            "date": "2017-01-10T12:00:00Z"
        },
        "contractTerms": {
            "hasElectronicPayment": true,
            "hasElectronicOrdering": true,
            "electronicInvoicingPolicy": "allowed"
        },
        "coveredBy": [
            "GPA"
        ],
        "selectionCriteria": {
            "criteria": [
                {
                    "type": "suitability",
                    "description": "Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015."
                },
                {
                    "type": "technical",
                    "description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All tendered Goods must comply with the MHRA Best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. (d) Potential Framework Participants and any sub-contractor(s) must possess a UKAS (or equivalent) accredited independent third party certificate of compliance with BS EN ISO 14001 (or equivalent) or a valid EMAS (or equivalent) certificate.",
                    "minimum": "(a) Confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products. (d) Confirmation of the existence of certificates drawn up by independent bodies attesting the compliance with the required environmental management systems or standards should be included in the Qualification Envelope of the ITT under Environmental Management Standards"
                }
            ]
        },
        "submissionTerms": {
            "languages": [
                "en"
            ],
            "bidValidityPeriod": {
                "durationInDays": 90
            }
        },
        "techniques": {
            "hasFrameworkAgreement": true,
            "frameworkAgreement": {
                "maximumParticipants": 1
            }
        },
        "classification": {
            "id": "33600000",
            "scheme": "CPV"
        },
        "reviewDetails": "The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts(Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
        "hasRecurrence": false
    },
    "language": "EN",
    "description": "The estimated value referred to in Sections II.1.7 and V.2.4 covers the initial twelve (12) months duration of the Framework Agreement and a twenty-four (24) months extension options. For further detail on the award of each individual product line please contact the Authority using the information supplied at the head of this notice. (SC Ref:488914)",
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000471605"
        },
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000471605"
        }
    ],
    "noticetype": "OJEU - F3 - Contract Award Notice",
    "awards": [
        {
            "id": "NP46517",
            "relatedLots": [
                "1"
            ]
        }
    ],
    "contracts": [
        {
            "id": "NP46517",
            "awardID": "NP46517",
            "status": "active",
            "dateSigned": "2017-03-06T00:00:00Z"
        }
    ],
    "relatedProcesses": [
        {
            "id": "1",
            "relationship": [
                "planning"
            ],
            "scheme": "EU-OJ",
            "identifier": "2016/S 229-417085"
        }
    ]
}